Table 1. Expression of the Extracellular... | American Society of Hematology

Table 1.

Expression of the Extracellular Domain of CD79b on the Membrane of CLL Cells

	Stage	CD19⁺/SN8⁺ %	sIg Intensity
1	0	1.4	w
2	0	5.6	w
3^*	0	6.3	w
4	0	0	w
5	0	14.6	w
6	0	95.5	b
7	I	23.2	w
8	I	0	w
9	I	4.6	w
10	I	3.3	w
11	I	1.8	w
12^*	II	81.4	b
13^*	II	11.3	w
14	II	3.9	w
15^*	II	26.5	w
16	II	61.0	w
17	II	6.7	w
18^*	II	1.9	w
19	II	0	w
20	II	0	w
21	II	19.9	w
22^*	II	93.0	w
23	II	8.4	w
24	III	2.4	w
25	III	62.0	b
26	III	20.5	b
27	III	81.8	w
28	III	34.5	w
29	III	97.7	w
30^*	IV	0	w
31^*	IV	3.3	w
32	IV	0	w
33	IV	0	w
34	IV	3.6	b
35	IV	50.4	w
36	IV	23.6	w
37	IV	11.7	w
38	IV	72.7	w
39	IV	100	w
40	IV	100	w
Normal controls (20)^†	86.6 ± 18.7		b
	(range, 76.8-98.3)

	Stage	CD19⁺/SN8⁺ %	sIg Intensity
1	0	1.4	w
2	0	5.6	w
3^*	0	6.3	w
4	0	0	w
5	0	14.6	w
6	0	95.5	b
7	I	23.2	w
8	I	0	w
9	I	4.6	w
10	I	3.3	w
11	I	1.8	w
12^*	II	81.4	b
13^*	II	11.3	w
14	II	3.9	w
15^*	II	26.5	w
16	II	61.0	w
17	II	6.7	w
18^*	II	1.9	w
19	II	0	w
20	II	0	w
21	II	19.9	w
22^*	II	93.0	w
23	II	8.4	w
24	III	2.4	w
25	III	62.0	b
26	III	20.5	b
27	III	81.8	w
28	III	34.5	w
29	III	97.7	w
30^*	IV	0	w
31^*	IV	3.3	w
32	IV	0	w
33	IV	0	w
34	IV	3.6	b
35	IV	50.4	w
36	IV	23.6	w
37	IV	11.7	w
38	IV	72.7	w
39	IV	100	w
40	IV	100	w
Normal controls (20)^†	86.6 ± 18.7		b
	(range, 76.8-98.3)

Abbreviations: w, weak; b, bright.

SN8 reactivity shown in Fig 2.

Number of cases.